NU-MED PLUS, INC.
Income Statement
| Line Item | Dec 2024 | Nov 2024 | Sep 2024 | Jun 2024 | May 2024 | Mar 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | $9.5K | — | — | $6.0K | — | — |
| Operating Income | — | — | $-17.4K | — | — | $-20.6K | — | — |
| Operating Margin | — | — | — | — | — | — | — | — |
| Interest Expense | — | — | — | — | — | $1.2K | — | — |
| Pretax Income | — | — | $-18.7K | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | — | — | — | — |
| Net Income | — | — | $-18.7K | $-17.3K | — | $-21.8K | — | — |
| Net Margin | — | — | — | — | — | — | — | — |
| EPS (Basic) | — | — | $0.00 | — | — | $0.00 | — | — |
| EPS (Diluted) | — | — | $0.00 | — | — | $0.00 | — | — |
| Shares Outstanding (Basic) | 83.5M | 83.5M | 81.3M | — | 83.5M | 83.5M | 83.5M | 83.5M |
| Shares Outstanding (Diluted) | 83.5M | 83.5M | 81.3M | — | 83.5M | 83.5M | 83.5M | 83.5M |
| Dividends Per Share | — | — | — | — | — | — | — | — |
People who invest make money for themselves; people who speculate make money for their brokers.